The analysts at investment bank Morgan Stanley have picked out their top bargain stocks in sectors that could benefit the most from the discovery of a coronavirus vaccine.

Morgan Stanley’s biotechnology team said they expect a widely available coronavirus vaccine by the first or second quarter of 2021.